Publications by authors named "G Vrioni"
The Resurgence of Infections and Reinfections during the COVID-19 Pandemic in Greece.
Int J Environ Res Public Health
September 2024
Article Synopsis
- * A study analyzed medical records over 14 months after the pandemic began, finding that among mainly men with a median age of 43, syphilis cases nearly doubled, particularly in individuals with HIV.
- * The study concluded that the pandemic was a significant factor in rising syphilis rates, underscoring the need for improved healthcare access and prevention strategies during future health crises.
Article Synopsis
- Trachoma is the leading infectious cause of blindness globally, primarily caused by serovars A-C of the bacterium Chlamydia trachomatis (Ct).
- The disease spreads through direct or indirect contact with infected ocular and nasal secretions, often in areas with poor hygiene and crowded living conditions.
- Chronic inflammation from repeated infections in early childhood can lead to severe complications like conjunctival scarring, trichiasis, corneal opacity, and ultimately, visual impairment.
Article Synopsis
- Candida auris cases in Greece rose significantly after 2019, leading to active surveillance from November 2019 to September 2021 in 11 hospitals, focusing on confirmed infections and outbreaks.
- A study identified 20 invasive infections and 25 colonized cases, with high mortality (53%) and common risk factors such as the use of indwelling devices and previous antibiotic treatments.
- The fungus showed resistance to fluconazole in all isolates and was mostly linked to a specific South Asian strain, highlighting the need for improved infection control measures in healthcare settings.
Objectives: Streptococcus pyogenes causes superficial infections but can also cause deep-seated infections and toxin-mediated diseases. In the present study, phylogenetic and in silico prediction analyses were performed on an antimicrobial resistant M1S. pyogenes strain causing severe clinical manifestations during the current surge of invasive group A Streptococcus (iGAS) disease.
View Article and Find Full Text PDFCarbapenem-resistant Gram-negative bacterial infections are a major public health threat due to the limited therapeutic options available. The introduction of the new β-lactam/β-lactamase inhibitors (BL/BLIs) has, however, altered the treatment options for such pathogens. Thus, four new BL/BLI combinations-namely, ceftazidime/avibactam, meropenem/vaborbactam, imipenem/relebactam, and ceftolozane/tazobactam-have been approved for infections attributed to carbapenem-resistant Enterobacterales species and .
View Article and Find Full Text PDF